Network·Venture Capital
📍 NEW YORK, NY
SEC CRD #801-121916
Sabrina Halper Show - Podcast - Apple Podcasts Sabrina Halper Show Sabrina Halper 5.0 (12) Technology Updated Biweekly The mind, the machine, and the meaning of it all. Latest Episode Follow Episodes May 20 Engineering Biology With AI: The Future of Medicine Jack Dent, co-founder of Chai Discovery, gives us a look at how AI could change the way we discover drugs, understand biology, and treat disease. Jack went from cold-emailing Stripe and joining as a teenager to co-founding Chai Discovery, the AI drug design company Sam Altman asked him and Josh to start years before they did. Chai has since raised $225M from investors including OpenAI and Thrive Capital, and built a model that hit a drug-design breakthrough far faster than expected, with roughly 200x better antibody success rates.We talk about whether people could one day help cure their own diseases with AI, whether each of us might have a personalized biology model, and whether medicine shifts from treating sickness to preventing it before it starts. Jack also gets into whether frontier AI labs will build these biology models themselves, what AI can and can’t fix in our current healthcare system, why clinical trials are still such a bottleneck, and how much of science may become less random when AI can generate and test better hypotheses. TIMESTAMPS: 00:00 Intro 02:28 Inside Stripe When It Was Only 100 People 08:45 How Sam Altman Sparked Chai’s Origin Story 10:52 Why Chai Discovery Exists 16:20 The Chai-2 Antibody Break
THOMAS DRESSER
CHIEF COMPLIANCE OFFICER AND GENERAL COUNSEL
📞 (646) 503-5030
🔒 Sign up for free to view key contact information
Sign up free →This profile has not yet been verified by the firm. Information may be incomplete or outdated. Claim this profile to take control of your listing.
AUM
$7.3B
Check Size
$225M–$225M
Location
NEW YORK, NY
Claim this profile to complete your information, set investment criteria, and start receiving curated deal flow from sponsors on DEALITHIC.